Publications by authors named "E Navarro"

Background: In the aftermath of the World Trade Center (WTC) attack on 11 September 2001, rescue and recovery workers faced hazardous conditions and toxic agents. Prior research linked these exposures to adverse health effects, but mainly examined individual factors, overlooking complex mixture effects.

Methods: This study applies an exposomic approach encompassing the totality of responders' experience, defined as the WTC exposome.

View Article and Find Full Text PDF

Preschool anxiety is highly prevalent and well known to predict risk for future psychopathology. The present study explores whether a diagnosis of an anxiety disorder in preschool interacts with (a) social skills and (b) cognitive ability to longitudinally predict psychopathology, two well-known protective factors, among a sample of 207 children measured at preschool (Mage = 4.34 years) and early childhood (Mage = 6.

View Article and Find Full Text PDF

Stress carries diverse implications for perceptual, cognitive, and affective functions. One population particularly susceptible to acute stress-induced cognitive changes are individuals with high-stress jobs (e.g.

View Article and Find Full Text PDF

Background: Advances in haemolytic disease of the fetus and newborn have led to numerous treatment options. We report practice variations in the management and outcomes of haemolytic disease of the fetus and newborn in at-risk pregnancies.

Methods: In this international, retrospective, observational cohort study, data from cases with moderate or severe haemolytic disease of the fetus and newborn were retrieved from 31 centres in 22 countries.

View Article and Find Full Text PDF
Article Synopsis
  • VCE-003.2, a derivative of cannabigerol, shows neuroprotective effects in Parkinson's disease models linked to mitochondrial dysfunction and neuroinflammation, now being tested against protein dysregulation associated with the disease.
  • Researchers administered an adeno-associated viral vector carrying a mutated α-synuclein gene to mice, causing motor impairments and neuron loss, then treated them with VCE-003.2 to assess its effects.
  • Results indicated that VCE-003.2 significantly improved motor performance, preserved neuron integrity, reduced microglia and astrocyte activation in the brain, and influenced gene expression related to immune responses, expanding its potential therapeutic benefits in Parkinson's disease.
View Article and Find Full Text PDF